3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
6
Phase 2
6
Phase NA
4
Phase 1/2
4
Phase 4
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Breast Neoplasms
24
Neoplasms
11
Carcinoma, Non-Small-Cell Lung
9
Prostatic Neoplasms
8
Multiple Myeloma
8
Lung Neoplasms
6
Melanoma
5
Leukemia, Myeloid, Acute
5
Neoplasm Metastasis
4
Glioma
4
Colorectal Neoplasms
4
Carcinoma, Hepatocellular
4
Tuberous Sclerosis
3
Stomach Neoplasms
3
Sarcoma
3
Papillomavirus Infections
3
Leiomyoma
3
Hematologic Neoplasms
3
Glioblastoma
3
Carcinoma, Renal Cell
3
Polycythemia Vera
2
Pain
2
Oligodendroglioma
2
Neoplasms by Site
2
Myasthenia Gravis
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Heart Failure
2
Febrile Neutropenia
2
Endometrial Neoplasms
2
Bronchiolitis Obliterans Syndrome
2
Interventions
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Lung Diseases
×
90 days
×
Clear all
NCT07279935
2026-06-01
REVIVE
AstraZeneca
Phase 4
Recruiting
100 enrolled